Table 3. Multivariate analysis on OS and PFS.
Characteristics | OS | PFS | ||||
---|---|---|---|---|---|---|
P | HR | 95% CI |
P | HR | 95% CI |
|
Age (≤65/>65) | 0.049 | 1.497 | 1.002–2.235 | 0.120 | 1.289 | 0.922–1.803 |
Male | 0.027 | 1.620 | 1.057–2.481 | 0.059 | 1.385 | 0.988–1.941 |
Histology (adenocarcinoma/squamous cell) | 0.766 | 1.092 | 0.610–1.955 | 0.693 | 1.108 | 0.665–1.847 |
Hemoglobin, g/dL (<13/≥13) | 0.317 | 1.245 | 0.810–1.914 | |||
Albumin, g/dL (<3.1/≥3.1) | 0.035 | 1.724 | 1.039–2.861 | 0.091 | 1.478 | 0.939–2.326 |
CRP, mg/dL (<2.68/≥2.68) | 0.011 | 1.713 | 1.130–2.599 | 0.138 | 1.289 | 0.922–1.803 |
COP-LMR (0,1,2) | 0.009 | 0.025 | ||||
COP-LMR 0 | - | 1 | Referent | - | 1 | Referent |
COP-LMR 1 | 0.021 | 1.822 | 1.096–3.027 | 0.116 | 1.347 | 0.929–1.951 |
COP-LMR 2 | 0.003 | 2.464 | 1.373–4.421 | 0.007 | 1.902 | 1.194–3.028 |
CI: confidence interval; COP-LMR: combination of platelet and lymphocyte to monocyte ratio; CRP: c-reactive protein; HR: hazard ratio; OS: overall survival; PFS: progression free survival.